http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 서동훈 (검색결과 163 건)
- 무료
- 기관 내 무료
- 유료
-
-
-
-
-
-
-
문화콘텐츠 개발을 위한 스토리텔링 전략 - ‘삼성현’을 중심으로 -
서동훈,김효정 영남대학교 민족문화연구소 2009 민족문화논총 Vol.43 No.-
Discovering and developing regional cultures became a basis for the competence in national competitiveness to be a pioneer in the wake of the globalization in the 21st Century, which is an era of culture. Gyeongsan is a highly historical region where the Great Teacher Wonhyo(Wonhyo Daesa), Seolchong, the Priest Ilyeon(Ilyeon Sunim) were born. They are called 'The Three Wise Men(Samsung-hyun)' and their common denominator was a respect for scholarship and emphasis on education. The aim of this study was to examine a strategy for storytelling to develop 'Samsung-hyun' as cultural contents. Developing 'Samsung-hyun' cultural contents can be defined as a series of traditional cultural contents business in which other cultural assets are utilized as a whole with the spirit of 'Samsung-hyun' in its center. The most crucial factor of such business for developing traditional cultural contents is to acquire a storytelling which enables an integrative identity formation. Storytelling is a basis for constructing cultural contents and a central medium of OSMU. Wonhyo is evaluated as a figure who made Buddhism accessible to the public and provided an ideology for the Unified Silla based on the popularization of Buddhism. His son, Seolchong, designed 'Idu letters' which are a means to write letters with borrowed symbols when there was no Hangul(Korean letters) available so that writings became easier. Ilyeon collected folk stories widely known to the public and wrote a uniquely Korean history book, Samguk-yusa. Ilyeon recorded the story of Wonhyo and Seolchong in Samguk-yusa and made it popular, hence three figures being intricately connected with one another. Moreover they were all excellent storytellers in that Wonhyo assimilated into the mass to invent and disseminate stories, Seolchong devised a medium for people to record, and Ilyeon wrote down the story of the two. 문화의 시대인 21세기를 맞아 지역문화의 개발은 세계화에 대응하여 시대를 이끌어갈 수 있는 국가 경쟁력의 기반이 되었다. 경산은 원효대사, 설총, 일연스님이 태어난 유서 깊은 고장이다. 이들은 세 명의 성현이라는 뜻에서 삼성현(三聖賢)이라 불린다. 이들의 공통점은 학문을 숭상하고 교육을 중시한 점이다. 본고는 ‘삼성현’을 문화콘텐츠로 개발하기 위한 스토리텔링 전략을 모색하고자 한다. ‘삼성현’ 문화콘텐츠 개발은 삼성현의 정신을 핵심으로 기타 문화자산을 총체적으로 이용하는 일련의 전통문화콘텐츠 사업이라고 할 수 있다. 이러한 전통문화콘텐츠 개발 사업에서 가장 중요한 것은 통합적인 정체성을 구현할만한 스토리텔링의 확보이다. 스토리텔링은 문화콘텐츠 구현의 근간이며 OSMU의 중심 매개이기 때문이다. 일연은 원효와 설총에 대한 이야기를 『삼국유사』에 기록하여 세상에 널리 알림으로써 동향인 세 사람은 각별한 인연으로 묶여있다. 대중 속으로 들어가 이야기를 만들고, 퍼트린 원효, 대중들에게 기록할 수 있는 매체를 발전시킨 설총, 그리고 이들의 이야기를 기록으로 남긴 일연 이들은 모두 탁월한 이야기꾼들이라 할 수 있다. 삼성현 문화콘텐츠 OSMU를 위한 방안으로는 첫째, ‘스토리텔링 공모전’ 등을 통해 삼성현에 대한 관심을 불러일으키는 한편, 우수한 작품을 발굴하여 제작 지원을 하는 것이다. 둘째, 교육콘텐츠의 개발이다. 삼성현이 학문을 숭상하고 교육을 중시했다는 공통점에 착안할 때 교육콘텐츠는 활성화는 매우 바람직한 방법이라 하겠다. 셋째, 체험콘텐츠의 활성화이다. 이러한 삼성현의 문화콘텐츠 개발을 통해 전통문화의 가치를 재인식함으로써 지역의 새로운 정체성 확립에 기여할 수 있을 것으로 기대된다.
-
-
Major clinical research advances in gynecologic cancer in 2017
서동훈,김미선,이경훈,엄근용,Maj Kamille Kjeldsen,Mansoor Raza Mirza,Jae Weon Kim 대한부인종양학회 2018 Journal of Gynecologic Oncology Vol.29 No.2
In 2017, 10 topics were selected as major clinical research advances in gynecologic oncology. For cervical cancer, efficacy and safety analysis results of a 9-valent human papillomavirus (HPV) vaccine and long-term impact of reduced dose of quadrivalent vaccine were updated. Brief introduction of KEYNOTE trials of pembrolizumab, a monoclonal antibody that blocks the interaction between programmed death (PD)-1 and its ligands, PD-L1 and PD-L2, followed. Tailored surveillance programs for gynecologic cancer related with Lynch syndrome and update on sentinel lymph node mapping were reviewed for uterine corpus cancer. For ovarian cancer, 5 topics were selected including poly(ADP-ribose) polymerases inhibitors and immunotherapy. The other potential practice changers covered in this review were lymphadenectomy in advanced disease, secondary cytoreductive surgery in recurrent disease, weekly dose-dense regimen for first-line chemotherapy, incorporation of bevacizumab maintenance in platinum-sensitive recurrent disease, and effect of platinum-free interval prolongation. Conflicting opinions of academic societies on periodic pelvic examination were introduced in conjunction with relevant literature review. For the field of radiation oncology, results of 2 big trials, The Postoperative Radiation Therapy in Endometrial Carcinoma-3 and Gynecologic Oncology Group-258, for endometrial cancer and recent advance in high-dose-rate brachytherapy for cervical cancer were reported. Topics for breast cancer covered adjuvant capecitabine after preoperative chemotherapy, adjuvant pertuzumab and trastuzumab in early human epidermal growth factor receptor 2-positive disease, olaparib for metastatic cancer in patients with a germline BRCA mutation, 20-year risks of recurrence after stopping endocrine therapy at 5 years, and contemporary hormonal contraception and the risk of breast cancer.
-
Major clinical research advances in gynecologic cancer in 2015
서동훈,김미선,김학재,이경훈,김재원 대한부인종양학회 2016 Journal of Gynecologic Oncology Vol.27 No.6
In 2015, fourteen topics were selected as major research advances in gynecologic oncology. For ovarian cancer, high-level evidence for annual screening with multimodal strategy which could reduce ovarian cancer deaths was reported. The best preventive strategies with current status of evidence level were also summarized. Final report of chemotherapy or upfront surgery (CHORUS) trial of neoadjuvant chemotherapy in advanced stage ovarian cancer and individualized therapy based on gene characteristics followed. There was no sign of abating in great interest in immunotherapy as well as targeted therapies in various gynecologic cancers. The fifth Ovarian Cancer Consensus Conference which was held in November 7–9 in Tokyo was briefly introduced. For cervical cancer, update of human papillomavirus vaccines regarding two-dose regimen, 9-valent vaccine, and therapeutic vaccine was reviewed. For corpus cancer, the safety concern of power morcellation in presumed fibroids was explored again with regard to age and prevalence of corpus malignancy. Hormone therapy and endometrial cancer risk, trabectedin as an option for leiomyosarcoma, endometrial cancer and Lynch syndrome, and the radiation therapy guidelines were also discussed. In addition, adjuvant therapy in vulvar cancer and the updated of targeted therapy in gynecologic cancer were addressed. For breast cancer, palbociclib in hormone-receptor-positive advanced disease, oncotype DX recurrence score in low-risk patients, regional nodal irradiation to internal mammary, supraclavicular, and axillary lymph nodes, and cavity shave margins were summarized as the last topics covered in this review.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
